{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:08:48Z","timestamp":1780560528823,"version":"3.54.1"},"reference-count":74,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"hy Co., Ltd."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: Hypertriglyceridemia is a critical cardiovascular risk factor, and the probiotic combination of Latilactobacillus curvatus HY7601 and Lactiplantibacillus plantarum KY1032 (HY+KY) has emerged as a potential therapeutic strategy, though clinical validation in adults with mild hypertriglyceridemia (HTG) is needed. Methods: In this randomized, double-blind, placebo-controlled, 12-week trial, a total of 100 overweight participants with mild HTG were randomized (n = 50 per group). Ultimately, 80 participants completed the study without major protocol violations and were evaluated in the Per-Protocol Set (probiotics group: n = 41; placebo group: n = 39). Primary outcomes included changes in serum lipid profiles such as triglycerides (TG) and LDL cholesterol (LDL), metabolic biomarkers, and gut microbiota composition analyzed via 16S rRNA gene sequencing. Results: HY+KY supplementation led to significant reductions in serum TG (158.61 \u00b1 23.17 to 139.54 \u00b1 54.31 mg\/dL, p = 0.009) and LDL (129.22 \u00b1 28.45 to 111.34 \u00b1 21.03 mg\/dL, p = 0.005) compared to baseline, while the placebo group showed no significant changes. Furthermore, the HY+KY group exhibited a significant increase in Apolipoprotein CII (ApoC2, p = 0.034) and a reduction in fasting glucose levels (p = 0.021). Microbiome analysis revealed that HY+KY significantly increased alpha diversity (Shannon index, p = 0.012) and significantly altered the microbial community structure (beta diversity, p = 0.015). Co-occurrence network analysis identified Lactiplantibacillus as a highly connected central node that is strongly associated with the favorable shifts in clinical biomarkers. Conclusions: HY+KY supplementation was associated with improved fasting TG and LDL profiles in adults with mild HTG, alongside coordinated changes in ApoC2, fasting glucose, and gut microbiota structure. These findings support the potential of probiotic supplementation as a preventive nutritional approach in borderline HTG.<\/jats:p>","DOI":"10.3390\/nu18111713","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:36:56Z","timestamp":1779892616000},"page":"1713","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Latilactobacillus curvatus HY7601 and Lactiplantibacillus plantarum KY1032 on Serum Triglyceride Levels and the Gut\u2013Metabolic Axis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2083-4117","authenticated-orcid":false,"given":"Eun-Ji","family":"Kim","sequence":"first","affiliation":[{"name":"R&BD Center, hy Co., Ltd., 22, Giheungdanji-ro 24beon-gil, Giheung-gu, Yongin-si 17086, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ki","family":"Hong","sequence":"additional","affiliation":[{"name":"R&BD Center, hy Co., Ltd., 22, Giheungdanji-ro 24beon-gil, Giheung-gu, Yongin-si 17086, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Dong","family":"Choi","sequence":"additional","affiliation":[{"name":"R&BD Center, hy Co., Ltd., 22, Giheungdanji-ro 24beon-gil, Giheung-gu, Yongin-si 17086, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Jung","family":"Shim","sequence":"additional","affiliation":[{"name":"R&BD Center, hy Co., Ltd., 22, Giheungdanji-ro 24beon-gil, Giheung-gu, Yongin-si 17086, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hwan","family":"Lee","sequence":"additional","affiliation":[{"name":"R&BD Center, hy Co., Ltd., 22, Giheungdanji-ro 24beon-gil, Giheung-gu, Yongin-si 17086, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Kil","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Vievis Namuh Hospital, 627, Nonhyeon-ro, Gangnam-gu, Seoul 06117, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"ref_1","unstructured":"(2025). Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990\u20132023. J. Am. Coll. Cardiol., 86, 2167\u20132243."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11886-011-0220-3","article-title":"The role of triglycerides in atherosclerosis","volume":"13","author":"Talayero","year":"2011","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12933-014-0159-y","article-title":"Hypertriglyceridemia: A too long unfairly neglected major cardiovascular risk factor","volume":"13","author":"Tenenbaum","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: Impact on statin therapy\u2014European Atherosclerosis Society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Casula, M., Catapano, A.L., and Magni, P. (2022). Nutraceuticals for dyslipidaemia and glucometabolic diseases: What the guidelines tell us (and do not tell, yet). Nutrients, 14.","DOI":"10.3390\/nu14030606"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"m3109","DOI":"10.1136\/bmj.m3109","article-title":"Management of hypertriglyceridemia","volume":"371","author":"Simha","year":"2020","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"Ding","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lee, K., Kim, H.-J., Kim, J.-Y., Shim, J.-J., and Lee, J.-H. (2024). A mixture of Lactobacillus HY7601 and KY1032 regulates energy metabolism in adipose tissue and improves cholesterol disposal in high-fat-diet-fed mice. Nutrients, 16.","DOI":"10.3390\/nu16152570"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Human gut microbes associated with obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41574-018-0143-9","article-title":"Microbiota and metabolites in metabolic diseases","volume":"15","author":"Cani","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"He, J., Zhang, P., Shen, L., Niu, L., Tan, Y., Chen, L., Zhao, Y., Bai, L., Hao, X., and Li, X. (2020). Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176356"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Mutalub, Y.B., Abdulwahab, M., Mohammed, A., Yahkub, A.M., Al-Mhanna, S.B., Yusof, W., Tang, S.P., Rasool, A.H.G., and Mokhtar, S.S. (2022). Gut microbiota modulation as a novel therapeutic strategy in cardiometabolic diseases. Foods, 11.","DOI":"10.3390\/foods11172575"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2012.02593.x","article-title":"Probiotics, their health benefits and applications for developing healthier foods: A review","volume":"334","author":"Nagpal","year":"2012","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/advances\/nmy063","article-title":"Mechanisms of action of probiotics","volume":"10","author":"Gil","year":"2019","journal-title":"Adv. Nutr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mnfr.201400548","article-title":"The perspective on cholesterol-lowering mechanisms of probiotics","volume":"59","author":"Ishimwe","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wu, Y., Zhang, Q., Ren, Y., and Ruan, Z. (2017). Effect of probiotic Lactobacillus on lipid profile: A systematic review and meta-analysis of randomized, controlled trials. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178868"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10408398.2021.2004578","article-title":"Probiotics act as a potent intervention in improving lipid profile: An umbrella systematic review and meta-analysis","volume":"63","author":"Zarezadeh","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"127336","DOI":"10.1016\/j.micres.2023.127336","article-title":"In vitro models to study human gut-microbiota interactions: Applications, advances, and limitations","volume":"270","author":"Qi","year":"2023","journal-title":"Microbiol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Mataigne, V., Vannier, N., Vandenkoornhuyse, P., and Hacquard, S. (2021). Microbial systems ecology to understand cross-feeding in microbiomes. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.780469"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s40168-025-02156-0","article-title":"Systematic pairwise co-cultures uncover predominant negative interactions among human gut bacteria","volume":"13","author":"Zhu","year":"2025","journal-title":"Microbiome"},{"key":"ref_27","first-page":"5","article-title":"Metagenomics, metatranscriptomics, and metabolomics approaches for microbiome analysis: Supplementary issue: Bioinformatics methods and applications for big metagenomics data","volume":"12","author":"Huang","year":"2016","journal-title":"Evol. Bioinform."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40168-024-01868-z","article-title":"Networks as tools for defining emergent properties of microbiomes and their stability","volume":"12","author":"Kajihara","year":"2024","journal-title":"Microbiome"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1535370219836771","article-title":"Mapping the microbial interactome: Statistical and experimental approaches for microbiome network inference","volume":"244","author":"Dohlman","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tim.2016.11.008","article-title":"Disentangling interactions in the microbiome: A network perspective","volume":"25","author":"Layeghifard","year":"2017","journal-title":"Trends Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nrmicro2832","article-title":"Microbial interactions: From networks to models","volume":"10","author":"Faust","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Park, D.-Y., Ahn, Y.-T., Park, S.-H., Huh, C.-S., Yoo, S.-R., Yu, R., Sung, M.-K., McGregor, R.A., and Choi, M.-S. (2013). Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059470"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1089\/jmf.2010.1355","article-title":"The inhibitory effect of Lactobacillus plantarum KY1032 cell extract on the adipogenesis of 3T3-L1 Cells","volume":"14","author":"Park","year":"2011","journal-title":"J. Med. Food"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.atherosclerosis.2015.06.030","article-title":"Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduces fasting triglycerides and enhances apolipoprotein AV levels in non-diabetic subjects with hypertriglyceridemia","volume":"241","author":"Ahn","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ctcp.2015.12.003","article-title":"Effects of pomegranate extract supplementation on inflammation in overweight and obese individuals: A randomized controlled clinical trial","volume":"22","author":"Hosseini","year":"2016","journal-title":"Complement. Ther. Clin. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: High-resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat. Methods"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1089\/jmf.2017.4157","article-title":"Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 Cell Extracts Inhibit Adipogenesis in 3T3-L1 and HepG2 Cells","volume":"21","author":"Jeung","year":"2018","journal-title":"J. Med. Food"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3746\/pnf.2019.24.2.136","article-title":"Oral administration of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 with Cinnamomi ramulus extract reduces diet-induced obesity and modulates gut microbiota","volume":"24","author":"Jeung","year":"2019","journal-title":"Prev. Nutr. Food Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jff.2015.10.006","article-title":"Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduced body adiposity and Lp-PLA2 activity in overweight subjects","volume":"19","author":"Jung","year":"2015","journal-title":"J. Funct. Foods"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: An Endocrine Society clinical practice guideline","volume":"97","author":"Berglund","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/MNM-160065","article-title":"A randomized clinical trial evaluating a proprietary mixture of Lactobacillus plantarum strains for lowering cholesterol","volume":"9","author":"Fuentes","year":"2016","journal-title":"Mediterr. J. Nutr. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Sohn, M., Na, G.Y., Chu, J., Joung, H., Kim, B.-K., and Lim, S. (2022). Efficacy and safety of Lactobacillus plantarum K50 on lipids in Koreans with obesity: A randomized, double-blind controlled clinical trial. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.790046"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Hori, M., Imamura, T., Narang, N., Onoda, H., Tanaka, S., Ushijima, R., Sobajima, M., Fukuda, N., Ueno, H., and Kinugawa, K. (2021). Triglyceride and small dense LDL-Cholesterol in patients with acute coronary syndrome. J. Clin. Med., 10.","DOI":"10.3390\/jcm10194607"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5551\/jat.RV17023","article-title":"Pathophysiology of diabetic dyslipidemia","volume":"25","author":"Hirano","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.metabol.2011.12.002","article-title":"A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease","volume":"61","author":"Kei","year":"2012","journal-title":"Metabolism"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","article-title":"Overproduction of very low\u2013density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome","volume":"28","author":"Adiels","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11552","article-title":"Functional interactions between the gut microbiota and host metabolism","volume":"489","author":"Tremaroli","year":"2012","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/CIRCRESAHA.115.306807","article-title":"The gut microbiome contributes to a substantial proportion of the variation in blood lipids","volume":"117","author":"Fu","year":"2015","journal-title":"Circ. Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Mo, S.-J., Lee, K., Hong, H.-J., Hong, D.-K., Jung, S.-H., Park, S.-D., Shim, J.-J., and Lee, J.-L. (2022). Effects of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 on overweight and the gut microbiota in humans: Randomized, double-blinded, placebo-controlled clinical trial. Nutrients, 14.","DOI":"10.3390\/nu14122484"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"k2179","DOI":"10.1136\/bmj.k2179","article-title":"Role of the gut microbiota in nutrition and health","volume":"361","author":"Valdes","year":"2018","journal-title":"BMJ"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","volume":"500","author":"Nielsen","year":"2013","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Vacca, M., Celano, G., Calabrese, F.M., Portincasa, P., Gobbetti, M., and De Angelis, M. (2020). The controversial role of human gut lachnospiraceae. Microorganisms, 8.","DOI":"10.3390\/microorganisms8040573"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Hidalgo-Cantabrana, C., Delgado, S., Ruiz, L., Ruas-Madiedo, P., S\u00e1nchez, B., and Margolles, A. (2018). Bifidobacteria and their health-promoting effects. Bugs as Drugs: Therapeutic Microbes for the Prevention and Treatment of Disease, Wiley.","DOI":"10.1128\/9781555819705.ch3"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.chom.2007.06.010","article-title":"Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae","volume":"2","author":"Lupp","year":"2007","journal-title":"Cell Host Microbe"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/imm.12760","article-title":"The immune response to Prevotella bacteria in chronic inflammatory disease","volume":"151","author":"Larsen","year":"2017","journal-title":"Immunology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.numecd.2015.05.002","article-title":"The triglyceride-lowering effect of supplementation with dual probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032: Reduction of fasting plasma lysophosphatidylcholines in nondiabetic and hypertriglyceridemic subjects","volume":"25","author":"Ahn","year":"2015","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.2337\/db22-0168","article-title":"Butyrate-producing bacteria and insulin homeostasis: The microbiome and insulin longitudinal evaluation study (MILES)","volume":"71","author":"Cui","year":"2022","journal-title":"Diabetes"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"R\u00edos-Covi\u00e1n, D., Ruas-Madiedo, P., Margolles, A., Gueimonde, M., De Los Reyes-gavil\u00e1n, C.G., and Salazar, N. (2016). Intestinal short chain fatty acids and their link with diet and human health. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00185"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/eji.201646879","article-title":"The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease","volume":"48","author":"Ascher","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/CIRCRESAHA.116.309219","article-title":"Gut microbiome associates with lifetime cardiovascular disease risk profile among bogalusa heart study participants","volume":"119","author":"Kelly","year":"2016","journal-title":"Circ. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13040-024-00356-2","article-title":"Assessment of the causal relationship between gut microbiota and cardiovascular diseases: A bidirectional Mendelian randomization analysis","volume":"17","author":"Dai","year":"2024","journal-title":"BioData Min."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/art.42331","article-title":"Alterations of gut microbiome, metabolome, and lipidome in Takayasu arteritis","volume":"75","author":"Fan","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Peeters, J., Thas, O., Shkedy, Z., Kodalci, L., Musisi, C., Owokotomo, O.E., Dyczko, A., Hamad, I., Vangronsveld, J., and Kleinewietfeld, M. (2021). Exploring the microbiome analysis and visualization landscape. Front. Bioinform., 1.","DOI":"10.3389\/fbinf.2021.774631"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.123.063914","article-title":"Streptococcus species abundance in the gut is linked to subclinical coronary atherosclerosis in 8973 participants from the SCAPIS cohort","volume":"148","author":"Dekkers","year":"2023","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41522-023-00448-7","article-title":"The therapeutic value of bifidobacteria in cardiovascular disease","volume":"9","author":"Tang","year":"2023","journal-title":"npj Biofilms Microbiomes"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"105150","DOI":"10.1016\/j.ebiom.2024.105150","article-title":"Gut microbial metabolism is linked to variations in circulating non-high density lipoprotein cholesterol","volume":"104","author":"Zhou","year":"2024","journal-title":"EBioMedicine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cell.2012.07.008","article-title":"Host remodeling of the gut microbiome and metabolic changes during pregnancy","volume":"150","author":"Koren","year":"2012","journal-title":"Cell"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Jiang, D., Armour, C.R., Hu, C., Mei, M., Tian, C., Sharpton, T.J., and Jiang, Y. (2019). Microbiome multi-omics network analysis: Statistical considerations, limitations, and opportunities. Front. Genet., 10.","DOI":"10.3389\/fgene.2019.00995"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41579-018-0024-1","article-title":"Keystone taxa as drivers of microbiome structure and functioning","volume":"16","author":"Banerjee","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature18846","article-title":"Diet\u2013microbiota interactions as moderators of human metabolism","volume":"535","author":"Sonnenburg","year":"2016","journal-title":"Nature"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1126\/science.aad2602","article-title":"The ecology of the microbiome: Networks, competition, and stability","volume":"350","author":"Coyte","year":"2015","journal-title":"Science"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1038\/s41467-022-31343-y","article-title":"Co-occurrence networks reveal more complexity than community composition in resistance and resilience of microbial communities","volume":"13","author":"Gao","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/11\/1713\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:44:52Z","timestamp":1780559092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/11\/1713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":74,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["nu18111713"],"URL":"https:\/\/doi.org\/10.3390\/nu18111713","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}